Quell is an FDA cleared, over-the-counter wearable therapeutic device for chronic pain. Quell is a 100% drug free solution that combines advanced neurotechnology in a wearable format with a sophisticated app for users to personalize and control therapy while tracking their pain and relevant health metrics.
READ MOREVisit Quell videoQuell is a 100% drug free wearable designed to provide relief for people suffering with chronic pain. Using advanced neurotechnology, Quell stimulates sensory nerves, tapping into the body’s pain response system.
Quell is the only device of its kind that is FDA cleared for use while sleeping – an especially critical feature for those living with chronic pain who often lose sleep due to pain symptoms, creating a vicious cycle that affects them into the following day. Users have the option to personalize and manage their therapy discreetly via the Quell app, which offers therapy utilization, sleep, activity and pain tracking. Quell offers those living with chronic pain another option to manage their condition without introducing a co-pay or prescription. With Quell, those living with chronic pain are empowered to reclaim their lives. Quell is available online at QuellRelief.com, and through select healthcare professionals and retailers.
The Quell Health Cloud is rapidly becoming the largest pain management clinical database. The deidentified user data collected from Quell users has already powered clinical research published in the Journal of Pain Research and presented at a number of scientific conferences.
READ MOREThe Quell Health Cloud has collected over 15 million hours of patient data including usage, therapy, sleep, activity and gait. The Quell Health Cloud will provide customers with real-time guidance to help optimize therapy and will increase the understanding of chronic pain at a population level.
A highly accurate and efficient point-of-care test for detecting diabetic peripheral neuropathy, one of the most common and costly complications of diabetes.
READ MOREVISIT DPNCheckDPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. The device measures nerve conduction velocity and response amplitude of the sural nerve, a nerve in the lower leg and ankle. These parameters are widely recognized as sensitive and specific biomarkers of DPN.
A point-of-care diagnostic platform for assessing common neuropathies.
READ MOREThe ADVANCE System is a NeuroMetrix legacy product. Although the device is no longer marketed, we maintain and supply a large customer base that continues to utilize our disposable electrodes. For users, the ADVANCE System provides efficient and convenient nerve conduction studies at the point-of-care setting. ADVANCE allows physicians to immediately assess and a establish treatment plan for their patients. ADVANCE is used with proprietary nerve-specific electrode arrays for accuracy and standardization.
